AstraZeneca and Regeneron to develop obesity treatmentsAstraZeneca has entered into a collaboration with Regeneron to research, develop and commercialise small molecule compounds directed...
Standardisation of OAGB is key to reducing surgical errors and ensuring consistent patient outcomes21 hours ago